期刊
JOURNAL OF CLINICAL MEDICINE
卷 10, 期 13, 页码 -出版社
MDPI
DOI: 10.3390/jcm10132898
关键词
migraine; botulinum toxin; predictors of efficacy
OnaB-A has been shown to be effective in preventing chronic migraines based on extensive clinical evidence, but there is still limited ability to predict a meaningful clinical response for individual patients. Recent developments in the field are focused on improving this predictive capability.
The efficacy of onabotulinumtoxinA (OnaB-A) as a preventative treatment for chronic migraine, emerging fortuitously from clinical observation is now supported by class one evidence and over two decades of real-world clinical data. There is still limited ability to predict a clinically meaningful response to OnaB-A for individual patients, however. This review summarises briefly the proposed mechanism of OnaB-A in chronic migraine, the literature of predictors of clinical response, and recent developments in the field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据